Terminated PHASE2 INTERVENTIONAL NCT00284024

Effectiveness of Domperidone to Increase Breastmilk Supply in Mothers With Low Supply

Assessing the Feasibility of Testing Domperidone's Effect on Breastfeeding in Women With Insufficient Breast Milk: An RCT Pilot Study

Sponsor: Hamilton Health Sciences Corporation

Conditions Insufficient Breastmilk Production

Interventions domperidone

Updated 5 times since 2017 Last updated: Oct 11, 2007 Started: Sep 30, 2006 Completion: Sep 30, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Unable to recruit participants

Other terminated trials from Hamilton Health Sciences Corporation

More terminations from Hamilton Health Sciences Corporation

Listed as NCT00284024, this PHASE2 trial focuses on Insufficient Breastmilk Production and remains terminated or withdrawn. Sponsored by Hamilton Health Sciences Corporation, it has been updated 5 times since 2006, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE2
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE2
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE2

First recorded

Sep 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hamilton Health Sciences Corporation
The Physicians' Services Incorporated Foundation

Data source: McMaster University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hamilton, Canada